Prostaglandin Conjugates And Derivatives For Treating Glaucoma And Ocular Hypertension

Patent No. EP3206693 (titled "Prostaglandin Conjugates And Derivatives For Treating Glaucoma And Ocular Hypertension") was filed by Alcon on Oct 15, 2015. The application was issued on Aug 3, 2022.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
STADA ARZNEIMITTEL	Apr 27, 2023	HAMM & WITTKOPP

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Aug 6, 2024
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Aug 6, 2024
Communication to the parties concerning the termination of the opposition proceedings (proprietor)
May 2, 2024
Brief communication - Opposition proceedings
May 2, 2024
Brief communication - Opposition proceedings
May 2, 2024
Decision of the Opposition Division and instruction
May 2, 2024
Decision revoking the European patent
May 2, 2024
Decision revoking the European patent
May 2, 2024
Grounds for the decision (Annex) - opposition
May 2, 2024
Means of redress
May 2, 2024
Scanned annex to a communication - opposition procedure
May 16, 2023
Communication of a notice of opposition and request to file observations
May 16, 2023
Notice of further oppositions to opponent(s)
May 4, 2023
Communication of a notice of opposition - first information to patent proprietor
Apr 27, 2023
(Electronic) Receipt
Apr 27, 2023
Citation in opposition procedure - 001
Apr 27, 2023
Citation in opposition procedure - 002
Apr 27, 2023
Citation in opposition procedure - 003
Apr 27, 2023
Citation in opposition procedure - 004
Apr 27, 2023
Citation in opposition procedure - 005
Apr 27, 2023
Citation in opposition procedure - 006
Apr 27, 2023
Citation in opposition procedure - 007
Apr 27, 2023
Citation in opposition procedure - 008
Apr 27, 2023
Citation in opposition procedure - 009
Apr 27, 2023
Citation in opposition procedure - 010
Apr 27, 2023
Citation in opposition procedure - 011
Apr 27, 2023
Citation in opposition procedure - 012
Apr 27, 2023
Consolidated list of cited opposition documents
Apr 27, 2023
Notice of opposition
Apr 27, 2023
Notice of opposition
Aug 17, 2022
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Jul 26, 2022
Confirmation of revocation of automatic debit order
Jul 21, 2022
Letter relating to the automatic debiting procedure
Jul 7, 2022
Decision to grant a European patent
Jul 5, 2022
Refund of fees
Jun 21, 2022
(Electronic) Receipt
Jun 21, 2022
Filing of the translations of the claims
Jun 21, 2022
French translation of claims
Jun 21, 2022
German translation of the claims
Jun 21, 2022
Letter accompanying subsequently filed items
Mar 14, 2022
Bibliographic data of the European patent application
Mar 14, 2022
Communication about intention to grant a European patent
Mar 14, 2022
Intention to grant (signatures)
Mar 14, 2022
Text intended for grant (clean copy)
Mar 14, 2022
Text intended for grant (version for approval)
Feb 1, 2022
(Electronic) Receipt
Feb 1, 2022
Amended claims with annotations
Feb 1, 2022
Claims
Feb 1, 2022
Letter accompanying subsequently filed items
Feb 1, 2022
Request for correction/amendment of the text proposed for grant sent from 01.04.2012
Dec 20, 2021
Bibliographic data of the European patent application
Dec 20, 2021
Communication about intention to grant a European patent
Dec 20, 2021
Intention to grant (signatures)
Dec 20, 2021
Text intended for grant (clean copy)
Dec 20, 2021
Text intended for grant (version for approval)
Feb 15, 2021
(Electronic) Receipt
Feb 15, 2021
Amended claims with annotations
Feb 15, 2021
Amended description with annotations
Feb 15, 2021
Claims
Feb 15, 2021
Description
Feb 15, 2021
Letter accompanying subsequently filed items
Feb 15, 2021
Reply to communication from the Examining Division
Feb 11, 2021
Annex to the communication
Feb 11, 2021
Consultation by telephone/in person (with time limit)
Feb 11, 2021
Result of consultation by telephone/in person
Jun 2, 2020
(Electronic) Receipt
Jun 2, 2020
Amended claims with annotations
Jun 2, 2020
Amended claims with annotations
Jun 2, 2020
Amended claims with annotations
Jun 2, 2020
Claims
Jun 2, 2020
Claims
Jun 2, 2020
Claims
Jun 2, 2020
Letter accompanying subsequently filed items
Jun 2, 2020
Non-patent literature cited during the examination procedure
Jun 2, 2020
Reply to communication from the Examining Division
Jan 22, 2020
Communication of the registration of a transfer or change of name and/or address
Dec 18, 2019
(Electronic) Receipt
Dec 18, 2019
Annexes in respect of a client data request
Dec 18, 2019
Letter accompanying subsequently filed items
Dec 18, 2019
Submission concerning a transfer of rights (applicant)
Nov 26, 2019
Annex to the communication
Nov 26, 2019
Consultation by telephone/in person (with time limit)
Nov 26, 2019
Result of consultation by telephone/in person
Apr 29, 2019
Communication confirming withdrawal from representation
Apr 29, 2019
Communication of amended entries concerning the representative
Apr 24, 2019
(Electronic) Receipt
Apr 24, 2019
Letter accompanying subsequently filed items
Apr 24, 2019
Submission concerning change of applicant's representative
Apr 23, 2019
(Electronic) Receipt
Apr 23, 2019
Letter accompanying subsequently filed items
Apr 23, 2019
Submission concerning change of applicant's representative
Oct 31, 2018
(Electronic) Receipt
Oct 31, 2018
Amended claims with annotations
Oct 31, 2018
Claims
Oct 31, 2018
Letter accompanying subsequently filed items
Oct 31, 2018
Reply to communication from the Examining Division
Sep 4, 2018
Grant of extension of time limit (examination procedure)
Aug 30, 2018
(Electronic) Receipt
Aug 30, 2018
Letter accompanying subsequently filed items
Aug 30, 2018
Request for extension of time limit to communication from the Examining Division
Apr 24, 2018
Annex to the communication
Apr 24, 2018
Communication from Examining division including search results r.164(2)(b) EPC
Apr 24, 2018
Information on Search Strategy
Apr 24, 2018
Search results under rule 164(2)(b) EPC
Apr 10, 2018
Search started
Feb 1, 2018
Annex to the communication
Feb 1, 2018
Communication from the examining division with an Invitation to pay a search fee(s)
Jan 26, 2018
Examination started
Nov 30, 2017
Brief communication to applicant/representative (Legal Division)
Nov 29, 2017
Communication to designated inventor
Nov 21, 2017
(Electronic) Receipt
Nov 21, 2017
Letter accompanying subsequently filed items
Nov 21, 2017
Letter concerning the inventor
Jul 26, 2017
Notification on forthcoming publication of bibliographic data
Jul 12, 2017
Invitation to indicate correct address of inventor
Jun 29, 2017
Letter which had not been notified
Jun 1, 2017
Communication regarding comments on written opinion/amendment of application/payment of claims fee
May 29, 2017
Communication to designated inventor
May 29, 2017
Communication to designated inventor
May 29, 2017
Communication to designated inventor
May 10, 2017
(Electronic) Receipt
May 10, 2017
Amended claims filed after receipt of (European) search report
May 10, 2017
Amended claims with annotations
May 10, 2017
Request for entry into the European phase
May 2, 2017
Copy of the international preliminary report on patentability
Feb 24, 2017
Information on entry into European phase
May 17, 2016
Priority document (electronically transmitted)
Apr 21, 2016
Copy of the international search report
Apr 21, 2016
Published international application - A1
Mar 23, 2016
ISR: cited documents
Mar 21, 2016
Written opinion of the ISA, boxes No. I to VIII
Mar 21, 2016
Written opinion of the ISA, cover sheet
Mar 21, 2016
Written opinion of the ISA, supplemental box
Jan 13, 2016
Partial International Search Report
Nov 23, 2015
Notification of receipt of Search copy
Nov 10, 2015
Notification of the recording of a change
Oct 30, 2015
Abstract
Oct 30, 2015
Annex
Oct 30, 2015
Claims
Oct 30, 2015
Description
Oct 30, 2015
Fee calculation sheet for an international application
Oct 30, 2015
Notification Concerning Payment of Prescribed Fees (copy for ISA/EP)
Oct 30, 2015
Notification of the International Application Number and of the International Filing Date (copy for ISA/EP)
Oct 30, 2015
Request form for international application (copy for ISA/EP)
Oct 30, 2015
Submission concerning representation

EP3206693

ALCON

Application Number: EP15791399A
Filing Date: Oct 15, 2015
Status: Revoked; Aug 2, 2024
Publication Date: Aug 3, 2022
External Links: Slate, Register , Google Patents

IP Verse

Prostaglandin Conjugates And Derivatives For Treating Glaucoma And Ocular Hypertension

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP3206693